Article Versions Notes

Kowalczyk A, Zarychta J, Lejman M, Latoch E, Zawitkowska J. Clinical Implications of Isocitrate Dehydrogenase Mutations and Targeted Treatment of Acute Myeloid Leukemia with Mutant Isocitrate Dehydrogenase Inhibitors—Recent Advances, Challenges and Future Prospects. International Journal of Molecular Sciences. 2024; 25(14):7916. https://doi.org/10.3390/ijms25147916

Kowalczyk, Adrian, Julia Zarychta, Monika Lejman, Eryk Latoch, and Joanna Zawitkowska. 2024. "Clinical Implications of Isocitrate Dehydrogenase Mutations and Targeted Treatment of Acute Myeloid Leukemia with Mutant Isocitrate Dehydrogenase Inhibitors—Recent Advances, Challenges and Future Prospects" International Journal of Molecular Sciences 25, no. 14: 7916. https://doi.org/10.3390/ijms25147916

Kowalczyk, A., Zarychta, J., Lejman, M., Latoch, E., & Zawitkowska, J. (2024). Clinical Implications of Isocitrate Dehydrogenase Mutations and Targeted Treatment of Acute Myeloid Leukemia with Mutant Isocitrate Dehydrogenase Inhibitors—Recent Advances, Challenges and Future Prospects. International Journal of Molecular Sciences, 25(14), 7916. https://doi.org/10.3390/ijms25147916